INHALE-3 extension study: Inhaled technosphere insulin plus insulin degludec maintains glycemic control
A new study in the journal Diabetes Technology & Therapeutics evaluated the effects of a regimen of inhaled technosphere ...
EurekAlert!5d
Evaluation of inhaled technosphere insulin plus insulin degludec for adults with type 1 diabetes
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...
Study suggests inhaled technosphere insulin could be considered as an option for adults with type 1 diabetes
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
Healio3d
Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes
Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...
Knowridge Science Report8d
This drug lowers blood sugar and body weight faster than other diabetes drugs
A new study has found that the diabetes drug tirzepatide helps people lower their blood sugar and lose weight more quickly ...
Diabetes.co.uk9d
Automated insulin delivery systems beneficial for older adults with type 1 diabetes
Otherwise known as an artificial pancreas or closed-loop system, an automated insulin delivery (AID) system is a technology ...
New Insulin Medicine Proposed For People With Diabetes
Pharmac is seeking public feedback on a proposal to fund a new, additional type of insulin for people with diabetes from 1 May 2025. The new medicine (branded as Ryzodeg) is a combination of two other ...
pharmaphorum2d
Novo Nordisk’s diabetes treatments approved in EU
The approval covers all 27 European Union member states. Tresiba (insulin degludec) is a once-daily new-generation based insulin analogue with an ultra-long duration of action. Ryzodeg (insulin ...